We previously reported the association between elevated G1P3 expression and poor relapse free (RFS) and overall survival (OS) in ER+ breast cancer patients.3 Since there was a limited number of DMFS cases, G1P3’s effect on DMFS was unclear. This evidence concerns the gene IFI6 and breast cancer.